Disc Medicine Inc

For the period ended Sep 30, 2024. Filed Nov 12, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 12, 2024

IRON$81.26+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

	September 30,2024	December 31,2023
Assets ·
Current assets: ·
Cash and cash equivalents	$192,638	$360,382
Marketable securities	294,725	—
Prepaid expenses and other current assets	5,789	5,280
Total current assets	493,152	365,662
Property and equipment, net	79	170
Right-of-use assets, operating leases	1,678	1,930
Other assets	236	234
Total assets	$495,145	$367,996
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$3,553	$12,629
Accrued external research and development expenses	16,332	1,986
Other accrued expenses	5,512	6,159
Operating lease liabilities, current	76	665
Total current liabilities	25,473	21,439
Operating lease liabilities, non-current	1,712	1,436
Total liabilities	27,185	22,875
Commitments and contingencies (Note 14)
Stockholders’ equity:
Common stock, $0.0001 par value; 100,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 29,748,154 and 24,360,233 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	3	2
Additional paid-in capital	735,761	533,764
Accumulated other comprehensive income	741	—
Accumulated deficit	(268,545)	(188,645)
Total stockholders’ equity	467,960	345,121
Total liabilities and stockholders’ equity	$495,145	$367,996

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.